Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Papers
(The H4-Index of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Incorporating patient preferences and burden-of-disease in evaluating ALS drug candidate AMX0035: a Bayesian decision analysis perspective34
The correlation between social support, coping style, advance care planning readiness, and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study32
Correction32
The amyotrophic lateral sclerosis-health index (ALS-HI): development and evaluation of a novel outcome measure30
Clinical and demographical characteristics in a cohort of MND patients treated with riluzole. Differences between tablets and oral suspension26
Validity and reliability measures of the Swedish Karolinska version of the Edinburgh Cognitive and Behavioral ALS Screen (SK-ECAS)25
Rapid classification of a novel ALS-causing I149S variant in superoxide dismutase-125
Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: a ten year follow up study25
Single task-level, 2SD-based cutoffs for the Italian version of the Edinburgh Cognitive and Behavioral ALS screen (ECAS)23
Development, reliability, validity, and acceptability of the remote administration of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS)23
A novel heterozygous GRN deletion (c.302_315del) associated with behavioral variant frontotemporal dementia21
Impact of occupational categories on the incidence of amyotrophic lateral sclerosis in Sardinia Island, Italy20
Theme 5 Human Cell Biology and Pathology20
Challenges in medical care for amyotrophic lateral sclerosis: a survey of physicians from Republic of Bashkortostan (Russia), Belarus, and Kazakhstan19
Emerging strategies for interpreting variants of uncertain significance (VUS) in amyotrophic lateral sclerosis18
Residential exposure associations with ALS risk, survival, and phenotype: a Michigan-based case-control study17
Theme 7 Pre-Clinical Therapeutic Strategies17
0.039052963256836